Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapy in Behcet's disease.

T Sakane1, M Takeno

  • 1Department of Immunology and Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.

Skin Therapy Letter
|July 13, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hebb's Vision: The Structural Underpinnings of Hebbian Assemblies.

bioRxiv : the preprint server for biology·2025
Same author

Integrating EM and Patch-seq data: Synaptic connectivity and target specificity of predicted Sst transcriptomic types.

bioRxiv : the preprint server for biology·2023
Same author

Simultaneous evaluation of long-lasting knee synovitis in patients undergoing arthroplasty by power Doppler ultrasonography and contrast-enhanced MRI in comparison with histopathology.

Clinical and experimental rheumatology·2012
Same author

Phylogenetic study of the species within the family Streptomycetaceae.

Antonie van Leeuwenhoek·2011
Same author

A study of comparison between the nationwide epidemiological survey in 1991 and previous surveys on behçet's disease in Japan.

Environmental health and preventive medicine·2011
Same author

Completion rate and compliance of anti-tuberculosis chemoprophylaxis in patients with rheumatic disease receiving tumor necrosis factor antagonists.

Clinical and experimental rheumatology·2010
Same journal

Exosomes in Dermatology.

Skin therapy letter·2026
Same journal

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

Skin therapy letter·2026
Same journal

Erratum to: Deuruxolitinib for Alopecia Areata.

Skin therapy letter·2026
Same journal

Advances in the Management of Hyperhidrosis.

Skin therapy letter·2026
Same journal

Topical Ruxolitinib for the Treatment of Hidradenitis Suppurativa.

Skin therapy letter·2026
Same journal

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis.

Skin therapy letter·2026
See all related articles

Behçet's disease is an inflammatory condition causing recurrent oral and genital ulcers, skin lesions, and potential organ damage. Topical corticosteroids effectively manage mucocutaneous symptoms, but severe cases require further intervention.

Area of Science:

  • Rheumatology
  • Dermatology
  • Ophthalmology

Background:

  • Behçet's disease is a rare inflammatory disorder with unknown etiology.
  • It can affect multiple organ systems, including the gastrointestinal tract, central nervous system, and vasculature.
  • Ocular involvement may lead to blindness, and systemic complications can be life-threatening.

Purpose of the Study:

  • To summarize the key clinical features of Behçet's disease.
  • To highlight the common mucocutaneous manifestations.
  • To discuss the general treatment approach for mucocutaneous symptoms.

Main Methods:

  • This abstract is a summary of existing knowledge on Behçet's disease.
  • It reviews the typical clinical presentation and diagnostic indicators.

Related Experiment Videos

  • It outlines standard therapeutic strategies for mucocutaneous symptoms.

    • Main Results:

    • The majority of patients experience recurrent oral aphthous ulcers.
    • Over 70% of patients exhibit genital ulcers and various skin symptoms.
    • A positive pathergy test indicates cutaneous hypersensitivity in affected individuals.

    Conclusions:

    • Mucocutaneous symptoms are frequent and generally self-limiting in Behçet's disease.
    • Topical corticosteroids are often sufficient for managing these lesions.
    • Prompt treatment is crucial when vital organs like the eyes are involved.